Black:White Disparities in HIV Mortality in the United States: 1990–2009

  • Kristi L. Allgood
  • Bijou Hunt
  • Monique Glover Rucker



The aim of this study was to assess whether racial disparities in human immunodeficiency virus (HIV) mortality in the USA have changed over time.


Using vital records from the National Center for Health Statistics and census data from the US Census Bureau, we calculated the race- and gender-specific HIV mortality rates and corresponding racial rate ratios for non-Hispanic Blacks and non-Hispanic Whites in the USA for four 5-year increments from 1990–2009. Rates were age-adjusted using the 2000 USA standard population. Additionally, we calculated excess Black deaths for 2005–2009.


For the total, male, and female populations, we observed a statistically significant increase in the Black:White HIV mortality disparity between T1 (1990–1994) and T4 (2005–2009). The increasing disparity was due to the fact that the decrease in mortality rates from T1 to T4 was greater among Whites than Blacks. This disparity led to 5603 excess Black deaths in the USA at T4.


Previous research suggests that as HIV becomes more treatable, racial disparities widen, as observed in this study for both men and women. Existing disparities could be ameliorated if access to care were equal among these groups. Equal access would enable more individuals to achieve viral suppression, the final step of the HIV Care Continuum.


HIV mortality Disparities HIV excess deaths 



We would like to acknowledge the dedication, leadership and mentorship of Dr. Steven Whitman, former Executive Director of the Sinai Urban Health Institute, who passed away in July 2014. His work in the field of HIV early in the epidemic and his passion for ending health disparities has motivated this analysis.

Conflicts of Interest

The authors declare that they have no competing interests.

Informed Consent

No animal or human studies were carried out by the authors for this analysis.

Financial Disclosure

Monique Glover Rucker receives salary support from Gilead Sciences, Inc. as part of the HIV FOCUS program.


  1. 1.
    Centers for Disease Control and Prevention. HIV surveillance=—United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60:689–93.Google Scholar
  2. 2.
    Centers for Disease Control. Mortality attributable to HIV infection/AIDS—United States, 1981-1990. MMWR Morb Mortal Wkly Rep. 1991;40:41–4.Google Scholar
  3. 3.
    National Center for Health Statistics. Vital Statistics of the United States, 1987, Volume II - Mortality, Part A. Washington, D.C.: US Governmenet Printing Office; 1990.Google Scholar
  4. 4.
    Peters KD, Kochanek KD, Murphy SL. Deaths: final data for 1996. Hyattsville: National Center for Health Statistics; 1998.Google Scholar
  5. 5.
    Centers for Disease Control and Prevention. HIV Surveillance Report, Vol. 24. Accessed 3/5/2015.
  6. 6.
    An Q, Prejean J, Hall HI. Racial disparity in U.S. diagnoses of acquired immune deficiency syndrome, 2000–2009. Am J Prev Med. 2012;43:461–6. doi: 10.1016/j.amepre.2012.07.040.CrossRefPubMedGoogle Scholar
  7. 7.
    Centers for Disease Control and Prevention. LCWK10. Deaths, percent of total deaths, and rank order for 113 selected causes of death and Enterocolitis due to Clostridium difficile, by race and sex Unites States, 2011. National Center for Health Statistics; 2011.Google Scholar
  8. 8.
    National Center for Health Statistics. Vital statistics of the United States 1989 volume II - mortality, part a. National center for health statistics. Washington: US Government Printing Office; 1993.Google Scholar
  9. 9.
    Rubin MS, Colen CG, Link BG. Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective. Am J Public Health. 2010;100:1053–9. doi: 10.2105/ajph.2009.170241.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Ray M, Logan R, Sterne JA, Hernandez-Diaz S, Robins JM, Sabin C, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2010;24:123–37.CrossRefPubMedGoogle Scholar
  11. 11.
    Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New Engl J Med. 1998;338:853–60.CrossRefPubMedGoogle Scholar
  12. 12.
    Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Singh GK, Azuine RE, Siahpush M. Widening socioeconomic, racial, and geographic disparities in HIV/AIDS mortality in the united states, 1987-2011. Adv Prev Med. 2013;2013:657961.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of HIV infection in the United States, 2002-2011. JAMA. 2014;312(4):432–4.CrossRefPubMedGoogle Scholar
  15. 15.
    National Center for Health Statistics. Mortality - All County (micro-data), as compiled from data provided by 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. National Center for Health Statistics; 1990–2009.Google Scholar
  16. 16.
    Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Statistical Notes : from the Centers for Disease Control and Prevention/National Center for Health Statistics. 2001(20):1–10.Google Scholar
  17. 17.
    World Health Organization. International classification of diseases, ninth revision. Geneva, Switzerland: World Health Organization; 1980.Google Scholar
  18. 18.
    Centers for Disease Control and Prevention. A Guide to State Implementation of ICD-10 for Mortality Part II: Applying Comparability Ratios. Washington, D.C.: National Center for Health Statistics; 2000Google Scholar
  19. 19.
    World Health Organization. International classification of diseases, tenth revision. Geneva, Switzerland: World Health Organization; 1992.Google Scholar
  20. 20.
    Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principals and quantitative methods. Belmont, CA: Lifetime Learning Publications; 1982.Google Scholar
  21. 21.
    SAS Institute I. SAS. In. 9.2 for Windows ed. Cary, NC: SAS Institute, Inc.; 2002-2008.Google Scholar
  22. 22.
    Gamble VN, Stone D. U.S. policy on health inequities: the interplay of politics and research. J Health Polit Policy Law. 2006;31:93–126.CrossRefPubMedGoogle Scholar
  23. 23.
    Simard EP, Fransua M, Naishadham D, Jemal A. The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med. 2012;172:1591–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:1585–92.CrossRefPubMedGoogle Scholar
  25. 25.
    Harper S, Lynch J, Burris S, Davey SG. Trends in the black-white life expectancy gap in the United States, 1983-2003. JAMA. 2007;297:1224–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Merson MH, O'Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet. 2008;372:475–88.CrossRefPubMedGoogle Scholar
  28. 28.
    Hodder SL, Justman J, Haley DF, Adimora AA, Fogel CI, Golin CE, et al. Challenges of a hidden epidemic: HIV prevention among women in the United States. J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S69–73.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Moyer VA. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013;159:51–60.CrossRefPubMedGoogle Scholar
  30. 30.
    Palella Jr FJ, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1–17.PubMedGoogle Scholar
  32. 32.
    Mahmoudi E, Jensen GA. Diverging racial and ethnic disparities in access to physician care: comparing 2000 and 2007. Med Care. 2012;50:327–34.CrossRefPubMedGoogle Scholar
  33. 33.
    Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data--United States and 6 U.S. dependent area--2010. Vol 17. Atlanta, GA: U.S. Department of Health and Human Services; 2012.Google Scholar
  34. 34.
    Chen M, Rhodes PH, Hall IH, Kilmarx PH, Branson BM, Valleroy LA. Prevalence of undiagnosed HIV infection among persons aged >/=13 years—National HIV Surveillance System, United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2012;61(Suppl):57–64.PubMedGoogle Scholar
  35. 35.
    Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63:1113–7.PubMedGoogle Scholar
  36. 36.
    Centers for Disease Control and Prevention. Late versus early testing of HIV—16 Sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52:581–6.Google Scholar
  37. 37.
    Centers for Disease Control and Prevention. Late HIV testing - 34 states, 1996–2005. MMWR Morb Mortal Wkly Rep. 2009;58(24):661–5.Google Scholar
  38. 38.
    Hall HI, McDavid K, Ling Q, Sloggett A. Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001. Ann Epidemiol. 2006;16:824–33.CrossRefPubMedGoogle Scholar
  39. 39.
    Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013;173(14):1337–44.CrossRefPubMedGoogle Scholar
  40. 40.
    Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr. 2010;53:124–30.CrossRefPubMedGoogle Scholar
  41. 41.
    Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents: US Department of Health and Human Services, 2013.Google Scholar
  43. 43.
    Levine RS, Briggs NC, Kilbourne BS, King WD, Fry-Johnson Y, Baltrus PT, et al. Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996. Am J Public Health. 2007;97:1884–92.PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Levine RS, Rust GS, Pisu M, Agboto V, Baltrus PA, Briggs NC, et al. Increased Black-White disparities in mortality after the introduction of lifesaving innovations: a possible consequence of US federal laws. Am J Public Health. 2010;100:2176–84.PubMedCentralCrossRefPubMedGoogle Scholar
  45. 45.
    Murphy K, Hoover DR, Shi Q, Cohen M, Gandhi M, Golub ET, et al. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States. AIDS. 2013;27:2413–23.PubMedCentralCrossRefPubMedGoogle Scholar
  46. 46.
    Silverberg MJ, Leyden W, Quesenberry Jr CP, Horberg MA. Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009;24:1065–72.PubMedCentralCrossRefPubMedGoogle Scholar
  47. 47.
    Moore RD, Keruly JC, Bartlett JG. Improvement in the health of HIV-infected persons in care: reducing disparities. Clin Infect Dis. 2012;55:1242–51.PubMedCentralCrossRefPubMedGoogle Scholar
  48. 48.
    Muthulingam D, Chin J, Hsu L, Scheer S, Schwarcz S. Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr. 2013;63:112–9.CrossRefPubMedGoogle Scholar
  49. 49.
    McFall AM, Dowdy DW, Zelaya CE, Murphy K, Wilson TE, Young MA, et al. Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. J Acquir Immune Defic Syndr. 2013;64:289–98.CrossRefPubMedGoogle Scholar
  50. 50.
    Palella Jr FJ, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, et al. Increased mortality among publicly insured participants in the HIV outpatient study despite HAART treatment. AIDS. 2011;25:1865–76.CrossRefPubMedGoogle Scholar
  51. 51.
    Phelan JC, Link BG. Controlling disease and creating disparities: a fundamental cause perspective. J Gerontol B Psychol Sci Soc Sci. 2005;60(Spec No 2):27–33.CrossRefPubMedGoogle Scholar
  52. 52.
    Tehranifar P, Neugut AI, Phelan JC, Link BG, Liao Y, Desai M, et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev. 2009;18:2701–8.PubMedCentralPubMedGoogle Scholar
  53. 53.
    Call KT, McAlpine DD, Garcia CM, Shippee N, Beebe T, Adeniyi TC, et al. Barriers to care in an ethnically diverse publicly insured population: is health care reform enough? Med Care. 2014;52:720–7.CrossRefPubMedGoogle Scholar
  54. 54.
    Herrin J, Wesolowski LG, Heffelfinger JD, Bostick N, Hall HI, Ethridge SF, et al. HIV screening practices and hospital characteristics in the US, 2009-2010. Public Health Rep. 2013;128:161–9.PubMedCentralPubMedGoogle Scholar
  55. 55.
    Burke RC, Sepkowitz KA, Bernstein KT, Karpati AM, Myers JE, Tsoi BW, et al. Why don’t physicians test for HIV? A review of the US literature. AIDS. 2007;21:1617–24.CrossRefPubMedGoogle Scholar
  56. 56.
    Myers JJ, Koester KA, Dufour MS. Barriers and facilitators to enhancing HIV testing in publicly funded primary care clinics: findings from San Francisco. AIDS Educ Prev. 2011;23:84–95.CrossRefPubMedGoogle Scholar
  57. 57.
    Jenness SM, Murrill CS, Liu KL, Wendel T, Begier E, Hagan H. Missed opportunities for HIV testing among high-risk heterosexuals. Sex Transm Dis. 2009;36:704–10.CrossRefPubMedGoogle Scholar
  58. 58.
    Chin T, Hicks C, Samsa G, McKellar M. Diagnosing HIV infection in primary care settings: missed opportunities. AIDS Patient Care STDS. 2013;27:392–7.PubMedCentralCrossRefPubMedGoogle Scholar
  59. 59.
    Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38:96–103.CrossRefPubMedGoogle Scholar
  60. 60.
    Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis. 2009;199:991–8.CrossRefPubMedGoogle Scholar
  61. 61.
    Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002;117:233–51.PubMedCentralCrossRefPubMedGoogle Scholar
  62. 62.
    Johnston SS, Juday T, Seekins D, Hebden T, Fulcher N, Farr AM, et al. Patterns and correlates of linkage to appropriate HIV care after HIV diagnosis in the US Medicaid population. Sex Transm Dis. 2013;40:18–25.CrossRefPubMedGoogle Scholar
  63. 63.
    Bhattacharya J, Goldman D, Sood N. The link between public and private insurance and HIV-related mortality. J Health Econ. 2003;22:1105–22.CrossRefPubMedGoogle Scholar
  64. 64.
    Johnson EN, Roediger MP, Landrum ML, Crum-Cianflone NF, Weintrob AC, Ganesan A, et al. Race/ethnicity and HAART initiation in a military HIV infected cohort. AIDS Res Ther. 2014;11:10.PubMedCentralCrossRefPubMedGoogle Scholar
  65. 65.
    Siddiqi AE, Hu X, Hall HI. Mortality among blacks or African Americans with HIV infection—United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2015;64:81–6.PubMedGoogle Scholar
  66. 66.
    Valdez H, Chowdhry TK, Asaad R, Woolley IJ, Davis T, Davidson R, et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995–1999. Clin Infect Dis. 2001;32:1487–93.CrossRefPubMedGoogle Scholar
  67. 67.
    Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91–8.PubMedCentralCrossRefPubMedGoogle Scholar
  68. 68.
    Lindan CP, Hearst N, Singleton JA, Trachtenberg AI, Riordan NM, Tokagawa DA, et al. Underreporting of minority AIDS deaths in San Francisco Bay area, 1985-86. Public Health Rep. 1990;105:400–4.PubMedCentralPubMedGoogle Scholar
  69. 69.
    Scheer S, McQuitty M, Denning P, Hormel L, Stephens B, Katz M, et al. Undiagnosed and unreported AIDS deaths: results from the San Francisco Medical Examiner. J Acquir Immune Defic Syndr. 2001;27:467–71.CrossRefPubMedGoogle Scholar
  70. 70.
    National Center for Health Statistics. Vital statistics of the United States, 1985, volume II - mortality, part a. Washington, D.C.: US Governmenet Printing Office; 1988.Google Scholar
  71. 71.
    Rumptz MH, Tobias C, Rajabiun S, Bradford J, Cabral H, Young R, et al. Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDS. 2007;21 Suppl 1:S30–9.PubMedGoogle Scholar
  72. 72.
    Christopoulos KA, Massey AD, Lopez AM, Hare CB, Johnson MO, Pilcher CD, et al. Patient perspectives on the experience of being newly diagnosed with HIV in the emergency department/urgent care clinic of a public hospital. PLoS One. 2013;8, e74199.PubMedCentralCrossRefPubMedGoogle Scholar
  73. 73.
    Fagan JL, Beer L, Garland P, Valverde E, Courogen M, Hillman D, et al. The influence of perceptions of HIV infection, care, and identity on care entry. AIDS Care. 2012;24:737–43.CrossRefPubMedGoogle Scholar
  74. 74.
    Bauman LJ, Braunstein S, Calderon Y, Chhabra R, Cutler B, Leider J, et al. Barriers and facilitators of linkage to HIV primary care in New York City. J Acquir Immune Defic Syndr. 2013;64 Suppl 1:S20–6.PubMedCentralCrossRefPubMedGoogle Scholar
  75. 75.
    Rothman RE, Kelen GD, Harvey L, Shahan JB, Hairston H, Burah A, et al. Factors associated with no or delayed linkage to care in newly diagnosed human immunodeficiency virus (HIV)-1-infected patients identified by emergency department-based rapid HIV screening programs in two urban EDs. Acad Emerg Med. 2012;19:497–503.CrossRefPubMedGoogle Scholar
  76. 76.
    Beer L, Fagan JL, Garland P, Valverde EE, Bolden B, Brady KA, et al. Medication-related barriers to entering HIV care. AIDS Patient Care STDS. 2012;26:214–21.PubMedCentralPubMedGoogle Scholar
  77. 77.
    Bradford JB, Coleman S, Cunningham W. HIV System Navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS. 2007;21 Suppl 1:S49–58.PubMedGoogle Scholar
  78. 78.
    Liau A, Crepaz N, Lyles CM, Higa DH, Mullins MM, DeLuca J, et al. Interventions to promote linkage to and utilization of HIV medical care among HIV-diagnosed persons: a qualitative systematic review, 1996-2011. AIDS Behav. 2013;17:1941–62.CrossRefPubMedGoogle Scholar
  79. 79.
    Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24:2665–78.CrossRefPubMedGoogle Scholar
  80. 80.
    Christopoulos KA, Kaplan B, Dowdy D, Haller B, Nassos P, Roemer M, et al. Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency department. AIDS Patient Care STDS. 2011;25:439–44.PubMedCentralCrossRefPubMedGoogle Scholar
  81. 81.
    Gilman B, Hidalgo J, Thomas C, Au M, Hargreaves M. Linkages to care for newly diagnosed individuals who test HIV positive in nonprimary care settings. AIDS Patient Care STDS. 2012;26:132–40.CrossRefPubMedGoogle Scholar
  82. 82.
    Centers for Disease Control and Prevention. CDC - CAPUS - Demonstration Projects - Prevention Research - HIV/AIDS. (2015) Accessed: 3/20/2015.
  83. 83.
    Health Rescources and Services Administration. Ryan White HIV/AIDS Program - Part C. (2015) Accessed: 3/20/2015.
  84. 84.
    Pinkerton SD, Kibicho J, Galletly CL. Is the US AIDS drug assistance program cost-effective? AIDS Behav. 2013;17(1):1–4.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© W. Montague Cobb-NMA Health Institute 2015

Authors and Affiliations

  • Kristi L. Allgood
    • 1
  • Bijou Hunt
    • 1
  • Monique Glover Rucker
    • 2
  1. 1.Sinai Urban Health InstituteSinai Health SystemChicagoUSA
  2. 2.Department of MedicineSinai Health SystemChicagoUSA

Personalised recommendations